Parole firm wins $213M bioterror contract

PharmAthene, a biotech company considered the star of the county's business incubator, has won a multiyear deal worth up to $213 million to develop a treatment for nerve agents for the Pentagon.

News of the company's first government contract comes three years after it entered the Chesapeake Innovation Center in Parole, where it has been busy developing bioterrorism products to protect the military and civilians.

"This is terrific news for PharmAthene," said Stacey Jurchison, company spokesman. "It's a very substantial contract for the company. We're very pleased. We've had an excellent partnership with the Department of...